Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARBs vs ARBs + SGLT2i for Proteinuria in Normotensive Diabetic Patients
NCT07586371Phase 3Active, not recruiting
- Sponsor
- Dr Mudassar Saeed Pansota
- Start
- Apr 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in proteinuria, sponsored by Dr Mudassar Saeed Pansota. Started Apr 2026; status: active, not recruiting.
02
Drugs
empagliflozin
03
Conditions
proteinuria
Beyond the preview
Go deeper on NCT07586371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07586371.